Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
approval
Pharma
Tarsus' Xdemvy scores FDA nod for common eyelid disease
Xdemvy eyedrops are the first treatment for Demodex blepharitis, an eyelid disease caused by Demodex mites.
Zoey Becker
Jul 25, 2023 11:21am
Amicus' Pompe approval portends a showdown with Sanofi
Mar 28, 2023 10:25am
5 years after European nod, Chiesi wins FDA approval for Lamzede
Feb 17, 2023 10:09am
Keytruda-Lenvima combo gains FDA nod in endometrial cancer
Jul 22, 2021 11:52am
